Advanced Enzyme Tech (ADVENZYMES) Shareholding Pattern
NSE: ADVENZYMES • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding
43.04%
FII Holding
25.86%
DII Holding
5.51%
Public Holding
17.44%
Total Shareholders
68,051
As of
Dec 2025
View the latest shareholding pattern of Advanced Enzyme Tech (ADVENZYMES) including promoter, FII, DII, and public holdings.
Track ADVENZYMES ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See
Advanced Enzyme Tech value estimation )
Advanced Enzyme Tech (ADVENZYMES) Shareholding Summary
Promoters have decreased holding from 43.07% to 43.04% in Dec 2025
FII/FPI have increased holdings from 25.41% to 25.86% in Dec 2025
DIIs have decreased holdings from 6.41% to 5.51% in Dec 2025
Institutional investors have decreased holdings from 31.82% to 31.37% in Dec 2025
Public holding has increased from 16.95% to 17.44% in Dec 2025
Number of shareholders decreased from 69,637 to 68,051 in Dec 2025
ADVENZYMES Quarterly Ownership Changes
Quarter-over-quarter changes for Advanced Enzyme Tech from Sept 2025 to Dec 2025.
Promoter Holding Change
Sept 2025 to Dec 2025
FII Holding Change
Sept 2025 to Dec 2025
DII Holding Change
Sept 2025 to Dec 2025
Public Holding Change
Sept 2025 to Dec 2025
Advanced Enzyme Tech (ADVENZYMES) Quarterly Shareholding Trends
Visual breakdown of ADVENZYMES ownership distribution over time. Learn more about ADVENZYMES share price history .
Rising institutional holdings in ADVENZYMES often correlate with improved fundamentals. Check out ADVENZYMES P/B ratio history .
Download complete ADVENZYMES ownership data for offline analysis. Discover ADVENZYMES annual price range .
All Data
Quarterly
Annual
Period
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Dec 2025
43.04%
25.86%
5.51%
0.00%
17.44%
8.15%
100.00% 68,051
Sept 2025
43.07%
25.41%
6.41%
0.00%
16.95%
8.15%
99.99% 69,637
Jun 2025
43.08%
23.46%
8.45%
0.00%
16.92%
8.10%
100.01% 67,589
Mar 2025
43.08%
11.90%
8.19%
0.00%
16.68%
20.16%
100.01% 65,322
Dec 2024
42.93%
12.58%
8.18%
0.00%
16.11%
20.21%
100.01% 67,351
Sept 2024
42.95%
12.63%
8.02%
0.00%
16.04%
20.36%
100.00% 66,758
Jun 2024
43.02%
12.03%
8.08%
0.00%
16.42%
20.45%
100.00% 65,222
Mar 2024
43.49%
23.01%
7.56%
0.00%
15.43%
10.51%
100.00% 68,640
Dec 2023
43.62%
0.00%
5.42%
0.00%
15.90%
35.06%
100.00% 73,034
Sept 2023
45.92%
0.00%
5.84%
0.00%
15.28%
32.97%
100.01% 72,642
Jun 2023
46.52%
0.00%
7.59%
0.00%
14.23%
31.66%
100.00% 75,052
Mar 2023
49.87%
0.00%
5.73%
0.00%
13.28%
31.11%
99.99% 77,537
Dec 2022
49.87%
0.00%
5.64%
0.00%
13.43%
31.06%
100.00% 84,277
Sept 2022
49.87%
0.00%
5.36%
0.00%
13.37%
31.40%
100.00% 84,376
Jun 2022
52.70%
0.00%
6.05%
0.00%
15.14%
26.12%
100.01% 86,573
Mar 2022
52.70%
0.00%
6.46%
0.00%
15.21%
25.63%
100.00% 84,346
Dec 2021
52.71%
0.00%
8.50%
0.00%
14.87%
23.92%
100.00% 87,112
Sept 2021
52.55%
0.00%
8.32%
0.00%
15.31%
23.83%
100.01% 79,254
Jun 2021
52.30%
0.00%
8.23%
0.00%
14.31%
25.16%
100.00% 62,388
Mar 2021
55.38%
0.00%
7.29%
0.00%
13.51%
23.82%
100.00% 0
ADVENZYMES promoter holding above 50% indicates strong insider confidence. Explore the ADVENZYMES balance sheet details for detailed insights.
Quarter
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Dec 2025
43.04%
25.86%
5.51%
0.00%
17.44%
8.15%
100.00% 68,051
Sept 2025
43.07%
25.41%
6.41%
0.00%
16.95%
8.15%
99.99% 69,637
Jun 2025
43.08%
23.46%
8.45%
0.00%
16.92%
8.10%
100.01% 67,589
Mar 2025
43.08%
11.90%
8.19%
0.00%
16.68%
20.16%
100.01% 65,322
Dec 2024
42.93%
12.58%
8.18%
0.00%
16.11%
20.21%
100.01% 67,351
Sept 2024
42.95%
12.63%
8.02%
0.00%
16.04%
20.36%
100.00% 66,758
Jun 2024
43.02%
12.03%
8.08%
0.00%
16.42%
20.45%
100.00% 65,222
Mar 2024
43.49%
23.01%
7.56%
0.00%
15.43%
10.51%
100.00% 68,640
Dec 2023
43.62%
0.00%
5.42%
0.00%
15.90%
35.06%
100.00% 73,034
Sept 2023
45.92%
0.00%
5.84%
0.00%
15.28%
32.97%
100.01% 72,642
Jun 2023
46.52%
0.00%
7.59%
0.00%
14.23%
31.66%
100.00% 75,052
Mar 2023
49.87%
0.00%
5.73%
0.00%
13.28%
31.11%
99.99% 77,537
Quarterly data helps track institutional investment cycles.
Year
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Dec 2025
43.04%
25.86%
5.51%
0.00%
17.44%
8.15%
100.00% 68,051
Dec 2024
42.93%
12.58%
8.18%
0.00%
16.11%
20.21%
100.01% 67,351
Dec 2023
43.62%
0.00%
5.42%
0.00%
15.90%
35.06%
100.00% 73,034
Dec 2022
49.87%
0.00%
5.64%
0.00%
13.43%
31.06%
100.00% 84,277
Dec 2021
52.71%
0.00%
8.50%
0.00%
14.87%
23.92%
100.00% 87,112
Year-over-year trends reveal long-term ownership shifts.
Understanding Advanced Enzyme Tech (ADVENZYMES) Shareholding Pattern
Advanced Enzyme Tech shareholding pattern reveals who owns ADVENZYMES stock and how ownership changes over time. High promoter stakes in ADVENZYMES often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your ADVENZYMES trades. ADVENZYMES P/E comparison
Combine ADVENZYMES ownership analysis with price movements and financial performance for a complete investment picture. (See ADVENZYMES value investing )